×
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
S&P 500   3,911.74
DOW   31,500.68
QQQ   294.61
NYSE:HCA

HCA Healthcare Price Target, Predictions & Analyst Ratings

$182.33
+4.89 (+2.76%)
(As of 06/24/2022 12:00 AM ET)
Add
Compare
Today's Range
$177.72
$183.13
50-Day Range
$171.56
$275.16
52-Week Range
$169.13
$279.02
Volume
4.78 million shs
Average Volume
2.01 million shs
Market Capitalization
$53.87 billion
P/E Ratio
8.58
Dividend Yield
1.23%
Price Target
$258.76

HCA Healthcare (NYSE:HCA) Price Target and Consensus Rating (2022)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 21 Analyst Ratings

Consensus Analyst Price Target

$258.76
41.92% Upside
High Price Target$306.00
Average Price Target$258.76
Low Price Target$227.00
TypeCurrent
6/26/21 to 6/26/22
1 Month Ago
5/27/21 to 5/27/22
3 Months Ago
3/28/21 to 3/28/22
1 Year Ago
6/26/20 to 6/26/21
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
16 Buy rating(s)
16 Buy rating(s)
14 Buy rating(s)
15 Buy rating(s)
Hold
5 Hold rating(s)
5 Hold rating(s)
6 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$258.76$262.00$285.65$201.59
Predicted Upside41.92% Upside16.59% Upside14.67% Upside14.53% Upside
Get HCA Healthcare Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for HCA and its competitors with MarketBeat's FREE daily newsletter.


HCA Stock Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

HCA Stock Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

HCA Healthcare Stock vs. The Competition

TypeHCA HealthcareMedical CompaniesS&P 500
Consensus Rating Score
2.76
2.71
2.52
Consensus RatingModerate BuyBuyBuy
Predicted Upside41.92% Upside438.81% Upside29.98% Upside
News Sentiment RatingNeutral News
Neutral News
Neutral News
MarketBeat
Community Rating
Outperform Votes
1124
79.83%
Underperform Votes
284
20.17%
Avg. Outperform Votes
170
66.93%
Avg. Underperform Votes
84
33.07%
Avg. Outperform Votes
840
69.14%
Avg. Underperform Votes
375
30.86%

Historical HCA Healthcare Price Targets and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/21/2022Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$267.00 ➝ $256.00+46.20%
6/20/2022Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Set Target$255.00+47.31%
6/16/2022Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$240.00+39.84%
5/26/2022Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeMarket Perform ➝ Outperform$273.00 ➝ $271.00+27.96%
5/3/2022Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$290.00 ➝ $260.00+23.33%
4/26/2022BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$275.00 ➝ $240.00+14.01%
4/26/2022Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$275.00 ➝ $245.00+16.39%
4/26/2022UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$289.00 ➝ $241.00+14.49%
4/25/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$265.00 ➝ $241.00+13.18%
4/25/2022Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$310.00 ➝ $250.00+16.72%
4/25/2022Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$310.00 ➝ $275.00+31.63%
4/25/2022Wells Fargo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetEqual Weight$267.00 ➝ $227.00+8.65%
4/25/2022SVB Leerink
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$304.00 ➝ $273.00+29.61%
4/25/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$277.00 ➝ $254.00+20.58%
4/25/2022Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$296.00 ➝ $260.00+23.43%
12/21/2021JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOverweight ➝ Neutral$270.00+9.93%
10/25/2021William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Larew
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Perform
10/25/2021Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$275.00 ➝ $283.00+14.71%
10/25/2021Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Pito Chickering
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy$275.00 ➝ $306.00+21.92%
8/27/2021Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold ➝ Neutral
8/6/2021The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$252.00 ➝ $279.00+12.02%
7/9/2021Seaport Res Ptn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. France
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy
11/11/2020Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$149.00 ➝ $163.00+7.16%
10/27/2020Smith Barney Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$142.00 ➝ $155.00+16.54%
10/9/2020CSFB
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$143.00 ➝ $158.00+17.41%
7/23/2020SunTrust Banks
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$130.00 ➝ $150.00+22.53%
1/29/2020Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform$160.00 ➝ $180.00+23.71%
12/6/2019Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kevin Fischbeck
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy
(Data available from 6/26/2017 forward. View 10+ years of historical ratings with our analyst ratings screener.)












HCA Healthcare Price Target - Frequently Asked Questions

What is HCA Healthcare's consensus rating and price target?

According to the issued ratings of 21 analysts in the last year, the consensus rating for HCA Healthcare stock is Moderate Buy based on the current 5 hold ratings and 16 buy ratings for HCA. The average twelve-month price prediction for HCA Healthcare is $258.76 with a high price target of $306.00 and a low price target of $227.00. Learn more on HCA's analyst rating history.

Do Wall Street analysts like HCA Healthcare more than its competitors?

Analysts like HCA Healthcare stock more than the stock of other Medical companies. The consensus rating for HCA Healthcare is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how HCA compares to other companies.

Do MarketBeat users like HCA Healthcare more than its competitors?

MarketBeat users like HCA Healthcare stock more than the stock of other Medical companies. 79.83% of MarketBeat users gave HCA Healthcare an outperform vote while medical companies recieve an average of 66.93% outperform votes by MarketBeat users.

Is HCA Healthcare being upgraded by Wall Street analysts?

Over the previous 90 days, HCA Healthcare's stock had 1 upgrade by analysts.

Does HCA Healthcare's stock price have much upside?

According to analysts, HCA Healthcare's stock has a predicted upside of 18.14% based on their 12-month price targets.

This page (NYSE:HCA) was last updated on 6/26/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.